Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Name: Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
Published: 2007
License: Public Domain

GlaxoSmithKline · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

thrombosis

thrombosis, venous, superficial vein thrombosis, superficial thrombophlebitis, fondaparinux, deep vein thrombosis, venous thromboembolism treatment, thrombosis, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Related documents